Table 3.
Variable | L. sakei (CJLS03) (n=47) | Placebo (n=48) | P valuea | ||||
---|---|---|---|---|---|---|---|
|
|
||||||
Baseline | 12 weeks | P value | Baseline | 12 weeks | P value | ||
SBP, mm Hg | 126.0±12.9 | 128.6±10.0 | 0.131 | 124.6±11.2 | 126.2±10.8 | 0.251 | 0.678 |
| |||||||
DBP, mm Hg | 78.4±10.2 | 78.0±9.6 | 0.788 | 75.4±8.8 | 78.8±9.5 | 0.003 | 0.026 |
| |||||||
Fasting glucose, mg/dL | 101.8±10.8 | 102.5±15.8 | 0.659 | 103.8±17.7 | 103.1±13.4 | 0.690 | 0.553 |
| |||||||
HbA1c, % | 5.7±0.4 | 5.8±0.5 | 0.223 | 5.6±0.7 | 5.6±0.5 | 0.170 | 0.672 |
| |||||||
Insulin, μIU/mL | 10.9±3.9 | 11.5±6.9 | 0.514 | 11.5±4.9 | 13.1±9.6 | 0.217 | 0.487 |
| |||||||
HOMA-IR | 2.8±1.1 | 2.9±1.8 | 0.444 | 3.0±2.0 | 3.4±2.7 | 0.283 | 0.583 |
| |||||||
Glucagon, pg/mL | 174.8±131.6 | 180.7±138.4 | 0.603 | 167.2±111.0 | 163.0±100.2 | 0.689 | 0.512 |
| |||||||
Uric acid, mg/dL | 5.1±1.1 | 5.0±1.1 | 0.088 | 5.6±1.6 | 5.6±1.6 | 0.659 | 0.404 |
| |||||||
Protein, g/dL | 7.4±0.3 | 7.4±0.4 | 0.447 | 7.4±0.4 | 7.4±0.3 | 0.397 | 0.255 |
| |||||||
Albumin, g/dL | 4.4±0.2 | 4.4±0.2 | 0.945 | 4.4±0.2 | 4.5±0.2 | 0.013 | 0.091 |
| |||||||
Total bilirubin, mg/dL | 0.73±0.22 | 0.75±0.29 | 0.409 | 0.79±0.30 | 0.77±0.27 | 0.404 | 0.239 |
| |||||||
Total cholesterol, mg/dL | 201.3±28.4 | 197.4±43.2 | 0.465 | 199.0±36.1 | 205.2±40.7 | 0.058 | 0.105 |
| |||||||
Triglyceride, mg/dL | 125.6±64.1 | 129.0±83.2 | 0.754 | 128.3±62.0 | 134.2±63.5 | 0.461 | 0.850 |
| |||||||
HDL-C, mg/dL | 54.4±9.7 | 55.1±9.6 | 0.375 | 52.6±11.4 | 53.5±9.6 | 0.387 | 0.907 |
| |||||||
LDL-C, mg/dL | 116.8±20.4 | 115.6±24.0 | 0.620 | 117.1±27.4 | 118.2±28.6 | 0.626 | 0.486 |
| |||||||
Apolipoprotein A1, mg/dL | 142.3±17.0 | 144.1±15.8 | 0.242 | 138.3±22.9 | 139.9±18.2 | 0.480 | 0.913 |
| |||||||
Apolipoprotein B, mg/dL | 105.2±18.3 | 104.9±20.0 | 0.849 | 104.5±23.1 | 108.9±30.3 | 0.082 | 0.136 |
| |||||||
Free fatty acid, μEq/L | 675.2±250.9 | 574.9±217.1 | 0.011 | 563.9±199.8 | 569.7±216.3 | 0.868 | 0.041 |
| |||||||
ALP, IU/L | 75.2±21.3 | 78.2±23.0 | 0.117 | 70.0±16.4 | 72.6±17.7 | 0.020 | 0.870 |
| |||||||
AST, IU/L | 26.3±12.2 | 27.5±21.7 | 0.572 | 24.8±8.3 | 27.2±12.8 | 0.074 | 0.620 |
| |||||||
ALT, IU/L | 28.4±21.4 | 30.3±34.0 | 0.594 | 26.8±17.8 | 35.0±46.9 | 0.197 | 0.390 |
| |||||||
BUN, mg/dL | 12.6±3.4 | 12.8±3.2 | 0.576 | 13.4±3.2 | 13.7±3.6 | 0.428 | 0.855 |
| |||||||
Creatinine, mg/dL | 0.69±0.16 | 0.69±0.17 | 0.745 | 0.74±0.18 | 0.73±0.18 | 0.497 | 0.461 |
| |||||||
Calcium, mg/dL | 9.2±0.3 | 9.2±0.3 | 0.879 | 9.2±0.3 | 9.3±0.3 | 0.041 | 0.144 |
| |||||||
Phosphorus, mg/dL | 3.6±0.4 | 3.5±0.4 | 0.052 | 3.5±0.5 | 3.5±0.5 | 0.679 | 0.273 |
Values are expressed as mean±standard deviation. P values were calculated using paired t tests between the baseline and after 12 weeks.
SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen.
P values were calculated using Student’s t test for the difference between groups in the change from the baseline to 12 weeks.